Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06643312 · ClinicalTrials.gov registry record · NA
TPAD for Recovery of Standing After Severe SCI
A NA study of SCI - Spinal Cord Injury, sponsored by Kessler Foundation.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06643312 is a NA study of SCI - Spinal Cord Injury that is actively recruiting participants, run by Kessler Foundation. The registered enrollment target is 50 participants, above the 34-participant average among 13 other SCI - Spinal Cord Injury trials with a reported enrollment target (47% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06643312, a NA study of SCI - Spinal Cord Injury, is actively recruiting participants, sponsored by Kessler Foundation.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate how standing and sitting balance control is altered after spinal cord injury (SCI) and how a new type of robotic assistive device may be used to improve muscle function. This device is called the Tethered Pelvic Assist Device, or TPAD. The main aims are to: 1\. Examine muscle activation patterns generated during different types of standing in spinal cord injured individuals using robotic assistance or self-assistance for balance 2 and 3. Examine the effectiveness of robotic-assisted stand training in the improvement of posture control during different types of standing and sitting in spinal cord injured individuals. Participants will be placed into one of 5 groups based on a physical classification of their spinal cord injury: Group 1: * Individuals with SCI that can stand independently * Will receive TPAD training * Will undergo standing, posture, sitting, and stepping assessments * Participation in this group will last about six months Group 2: * Individuals with SCI that cannot stand independently * Will receive TPAD training * Will undergo standing, posture, sitting, and stepping assessments * Participation in this group will last about 6 months Group 3: * Individuals with SCI that can stand independently * Will undergo standing and posture assessments * Participation in this group will last about 2 weeks Group 4: * Individuals with SCI that cannot stand independently * Will undergo standing and posture assessments * Participation in this group will last about 2 weeks Group 5: * Individuals without a SCI * Will undergo standing, posture, and sitting assessments * Participation in this group will last about 2 weeks
Conditions Studied
Interventions
- DEVICE The Tethered Pelvic Assist Device (TPAD)
Study Locations (1)
New Jersey
- Kessler Foundation - West Orange
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-10-22 |
| Est. Completion | 2028-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06643312
The ClinicalTrials.gov registry entry for NCT06643312 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 34-participant average among 13 other SCI - Spinal Cord Injury trials with a reported enrollment target (47% higher). The listed sponsor is Kessler Foundation, which has 104 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with SCI - Spinal Cord Injury appearing as the primary indexed condition, and to 1 intervention - of which The Tethered Pelvic Assist Device (TPAD) is the first listed.
NCT06643312 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT06643312 about?
NCT06643312 is a clinical study titled "TPAD for Recovery of Standing After Severe SCI". The purpose of this study is to investigate how standing and sitting balance control is altered after spinal cord injury (SCI) and how a new type of robotic assistive device may be used to improve muscle function. This device is called the Tethered Pelvic Assist Device, or TPAD. The main aims are t...
What is the current status of trial NCT06643312?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-10-22. Estimated completion is 2028-01.
What conditions does trial NCT06643312 study?
This clinical trial studies the following conditions: SCI - Spinal Cord Injury.
What interventions are being tested in trial NCT06643312?
The interventions under investigation include: The Tethered Pelvic Assist Device (TPAD) (DEVICE).
Who is sponsoring clinical trial NCT06643312?
This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06643312 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for SCI - Spinal Cord Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Utilization Effects of Powered Wearable Orthotics in Improving Upper Extremity Function and ADL in Persons With SCI
RECRUITING · NA
-
Safety, Feasibility, and Efficacy of TSCS on Stabilizing Blood Pressure for Acute Inpatients With SCI
RECRUITING · NA
-
Epidural Stimulation After Neurologic Damage: Long-Term Outcomes
RECRUITING · NA
-
ECoG BMI for Motor and Speech Control
RECRUITING · NA
-
Improving Balance After Spinal Cord Injury Using a Robotic Upright Stand Trainer and Spinal Cord Epidural Stimulation
RECRUITING · NA
-
Gut-Brain Neural Coupling in Spinal Cord Injury
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.